Single and multiple dose evaluation of a novel MetAP2 inhibitor: Results of a randomised, double-blind, placebo-controlled clinical trial

Authors
Category Primary study
ConferenceDiabetologia
Year 2017
This article has no abstract
Epistemonikos ID: 6ec67652d77c549f62d30e1a5c0b1a94eaa46f33
First added on: Apr 29, 2026